Abstract
In this chapter, we discuss the two major sociolegal concepts relating to the regulation of PGD in practice: the importance of reproductive autonomy and the fear that embryo selection will return us to an era of eugenics. We then present the various levels at which PGD might be regulated, culminating in a summary of the pros and cons of government regulation vs. professional self-regulation. The UK’s Human Fertilisation and Embryology Authority’s system for regulating PGD is offered as one example of how policy can be developed in this scientific and moral gray area. The chapter concludes with a presentation of available data on both public and professional opinion regarding the appropriate uses and limitations of PGD. The “bottom line” is that in order to answer the question “should PGD be more regulated?”, we must first decide whether the present state of self-regulation is sufficient, which in turn depends on our views regarding government involvement in medical practice, reproductive autonomy, and whether or not current uses of PGD are morally troubling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
Robertson, John. “Assisting Reproduction, Choosing Genes and the Scope of Reproductive Autonomy.” The George Washington Law Review 76.6 (2008): 1490–1513.
Leslie-Miller, Jana. “From Buck to Bell: Responsible Reproduction in the Twentieth Century.” Maryland Journal of Contemporary Legal Issues 123.8 (1997): 123–150.
Berkowitz, Jonathan M. and Jack W. Snyder. “Racism and Sexism in Medically Assisted Conception.” Bioethics 12.1 (1998): 25–44.
Wilson, Robert. “Environmental Regulation of the Human Gene Pool as a Genetic Commons.” N.Y.U. Environmental Law Journal 5 (1996): 833–857.
Darnovsky, Marcy. “A Slippery Slope to Human Germline Modification.” Nature 499.7457 (2013): 127.
Lombardo, Paul A. Three Generations, No Imbeciles: Eugenics, the Supreme Court, and Buck v. Bell. Baltimore: Johns Hopkins University Press, 2008.
Galton, Francis. “Eugenics: Its Definition, Scope, and Aims.” American Journal of Sociology 10.1 (1904): 1–25.
Until recently, Italy had such a ban of PGD, but has recently begun to allow its use for a set of limited conditions. See Gianaroli, Luca, Anna Maria Crivello, Ilaria Stanghellini, Anna Pia Ferraretti, Carla Tabanelli, and Maria Cristina Magli. “Reiterative Changes in the Italian Regulation on IVF: The Effect on PGD Patients’ Reproductive Decisions.” Reproductive BioMedicine Online 28.1 (2013): 125–132.
Baruch S., G. Javitt, J. Scott, and K. Hudson. Preimplantation Genetic Diagnosis: A Discussion of Challenges, Concerns, and Preliminary Policy Options Related to the Genetic Testing of Human Embryos. Washington, DC: Genetics and Public Policy Center, 2004.
Murray, Thomas H., “Stirring the Simmering ‘Designer Baby’ Pot,” Science 343 (March 14, 2014 ): 1208–1210.
Gutierrez, Alberto. “Warning Letter to 23andMe, Inc.” Inspections, Compliance, Enforcement, and Criminal Investigations. Food and Drug Administration, November 22, 2013. Web. March 14, 2014.
Baruch S. et al. (2004) Reproductive Genetic Testing: Issues and Options for Policymakers.
Stankovic, Bratislav. “‘It’s a Designer Baby!’—Opinions on Regulation of Preimplantation Genetic Diagnosis.” UCLA Journal of Law and Technology 3 (2005): n. pag.
Yost, Judith. CLIA and Genetic Testing Oversight. Rep.: Center for Medicare and Medicaid Services, 2008.
Baruch S. et al. (2004) Reproductive Genetic Testing: Issues and Options for Policymakers.
Fossett, James W., Alicia R. Ouellette, Sean Philpott, David Magnus, and Glenn McGee. “Federalism and Bioethics: States and Moral Pluralism.” Hastings Center Report 37.6 (2007): 24–35.
Murray, Thomas H., “Stirring the Simmering ‘Designer Baby’ Pot,” Science 343 (March 14, 2014 ): 1208–1210.
Ethics Committee of the American Society for Reproductive Medicine. “Sex Selection and Preimplantation Genetic Diagnosis.” Fertility and Sterility 72.4 (1999): 595–598.
Grody, Wayne, Barry H. Thompson, Anthony R. Gregg, Lora H. Bean, Kristin G. Monaghan, Adele Schneider, and Roger V. Lebo. “ACMG Position Statement on Prenatal/Preconception Expanded Carrier Screening.” American College of Medical Genetics and Genomics. Genetics in Medicine 15.5 (2013): 482–483.
Simpson, Joe, Robert Rebar, and Sandra Carson. “Professional Self-Regulation for Preimplantation Genetic Diagnosis: Experience of the American Society for Reproductive Medicine and Other Professional Societies.” Fertility and Sterility 85 (2006): 1653–1660.
Von Hagel, Alison. “Banking on Infertility: Medical Ethics and the Marketing of Fertility Loans.” Hastings Center Report 43.6 (2013): 15–17.
Copyright information
© 2015 Michelle Bayefsky and Bruce Jennings
About this chapter
Cite this chapter
Bayefsky, M., Jennings, B. (2015). Regulating PGD in Practice. In: Regulating Preimplantation Genetic Diagnosis in the United States: The Limits of Unlimited Selection. Palgrave Series in Bioethics and Public Policy. Palgrave Pivot, New York. https://doi.org/10.1057/9781137515445_4
Download citation
DOI: https://doi.org/10.1057/9781137515445_4
Publisher Name: Palgrave Pivot, New York
Print ISBN: 978-1-349-50640-8
Online ISBN: 978-1-137-51544-5
eBook Packages: Palgrave Political Science CollectionPolitical Science and International Studies (R0)